Both in Testing Laboratories
20/20 Biolabs vs UL Solutions
Over the past year AIDX returned −99.0% and ULS returned −2.7%; their daily moves had a correlation of 0.72.
AIDX −99.0% ULS −2.7%Growth of $1, one year, split-adjusted
| Metric | AIDX | ULS |
|---|---|---|
| Price | $0.2349 | $80.40 |
| Market cap | $3.0M | $16.23B |
| Today | −0.04% | +7.00% |
| 1 month | −33.3% | +17.8% |
| 6 months | — | −23.2% |
| Year to date | — | +2.0% |
| 1 year | — | +3.2% |
| Revenue growth (YoY) | — | +5.2% |
| Gross margin | 41.7% | 51.1% |
| Net margin | −376.8% | 30.1% |
| P/E (TTM) | — | 32.1× |
| Price / sales | — | 5.2× |
| Net cash | $4.5M | $133.0M |
| Dividend yield | — | 0.72% |
| Volatility (60d) | — | 31.5% |
| Short % of float | 0.1% | 7.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).